Loibl S, Jassem J, Sonnenblick A, Parlier D, et al. Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update. J Clin Oncol 2024 Sep 11:JCO2302505. doi: 10.1200/JCO.23.02505.
PMID: 39259927